Live
Endpoints NewsBioNTech to scale down manufacturing, over 1,800 jobs on the lineEndpoints NewsParsley Health goes in-network nationwideBioPharma DiveViridian data lift prospects for thyroid eye disease drugFierceBiotechOlympus, EndoRobotics in distribution pact for robot-assisted endoscopic techBioWorldUCB onboards more autoimmune TCEs with $2.2B Candid buyBioWorldChina’s new IIT rules could reshape early stage drug developmentBioWorldBeone eyes Huahui Health’s trispecific HH-160 with $2B option dealBioWorldBio Korea 2026: US policy risks shift to execution frameworkBioWorldBio Korea 2026 kicks off with spotlight on oligonucleotidesEndpoints NewsSecond life for gene therapy; Takeda Phase 2/3 win; UK cancer biotech's $83MFierceBiotechMadrigal continues MASH deal spree with $1B biobucks license for Arrowhead asset rejected by J&JEndpoints NewsSwiss manufacturing, biotech industry so far unfazed by geopolitics
Thermo Fisher Jan 22, 2026

Thermo Fisher’s AI Lab Push And Leadership Shift Might Change The Case For Investing In TMO - simplywall.st

Thermo Fisher’s AI Lab Push And Leadership Shift Might Change The Case For Investing In TMO - simplywall.st

Original
Body unavailable. Use the original source.